The practical contribution is not a single pooled risk estimate, but a clinically interpretable map showing when respiratory recovery should be treated as cardiopulmonary transition-of-care, most consistently during the first month.
Abstract
Background
Cardiovascular events appear to cluster after acute exacerbation of chronic obstructive pulmonary disease (COPD), but the timing, severity gradient, and implications for respiratory follow-up remain incompletely organized.
Methods
PubMed, Embase, Scopus, and Web of Science were searched from inception to 1 May 2026. Adult observational studies and post hoc trial analyses were eligible when they evaluated clinically diagnosed cardiovascular events during or after exacerbations of COPD, asthma, or bronchiectasis. COPD was treated as the primary evidence base. Because designs, endpoints, severity definitions, comparators, and risk windows differed materially, results were synthesized as a time-windowed evidence map rather than as a pooled meta-analysis.
Results
The search identified 8,027 records; 4,866 unique records were screened, 55 full texts were assessed, and 34 records were retained for quantitative, sensitivity, or narrative evaluation. The extracted matrix contained 110 effect estimates, of which 101 related to COPD and 57 fell within 30-day windows after time-window harmonization. Early risk was consistently higher than later risk, especially after severe or hospitalized COPD exacerbations. Signals were observed for coronary events, ischemic stroke, heart failure, atrial fibrillation or arrhythmia, cardiovascular death, and composite severe cardiovascular outcomes. Asthma and bronchiectasis evidence was sparse and exploratory.
Conclusions
Severe or hospitalized COPD exacerbation identifies a short cardiovascular vulnerability window, most consistently during the first month. The practical contribution is not a single pooled risk estimate, but a clinically interpretable map showing when respiratory recovery should be treated as cardiopulmonary transition-of-care.
Postoperative atrial fibrillation (POAF) complicates 20–50% of cardiac surgical procedures and is associated with increased stroke risk, prolonged hospitalisation, and mortality. Numerous circulating and clinical biomarkers have been proposed for POAF risk stratification; however, diabetes, chronic kidney disease (CKD)...
O. Afolabi, M. Oluwajuyigbe, A. Adegbamigbe et al.· International Surgery Journa...· 0 citations
We aimed to gather and summarize evidence on the potential links between chronic venous disease (CVeD), cardiovascular events and mortality in adults. A systematic search of the PubMed database was conducted in accordance with PRISMA guidelines in October 2025. Observational studies or registries were eligible. Adults...
L. De Luca, V. Blanc-Guillemaud, M. Onselaer et al.· International Journal of Car...· 0 citations
T2-related biomarkers may add complementary information to adult asthma exacerbation-risk models, but the available evidence does not yet establish BEC, FeNO, or IgE as independently sufficient predictors or support routine implementation of an existing model.
AIM
To synthesise evidence from systematic reviews on triggers and modifiers of acute coronary events to identify clinical implications. Triggers refer to transient exposures that may precipitate acute coronary events through several potential biological and haemodynamic mechanisms.
DESIGN
An umbrella review.
DATA...
Lynne Hunt, M. Riegel, G. Tofler et al.· Journal of Advanced Nursing· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.